Clinical Trials

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05183243 2024-07-16

GH21 Capsules for Advanced Solid Tumors: A Study on Safety and Early Results

GastrointestinalHead & NeckThoracic

68 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT03724500 2024-05-22

Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer

65 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT06394427 2024-05-01

Neoadjuvant Chemoimmunotherapy in Stage IIIA- N2IIIB Non-small Cell Lung Cancer

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04622007 2024-04-30

KICKSTART

68 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04085250 2024-04-23

Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy

264 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05260606 2024-04-17

IBFIC

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05240131 2024-04-12

A Study to Investigate the Safety and Efficacy of GB1211 (a Galectin-3 Inhibitor) in Combination With Atezolizumab in Patients With Non-Small Cell Lung Cancer (NSCLC).

88 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05519293 2024-04-11

Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation

76 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05552781 2024-04-11

H002 in Patients With EGFR Mutation Locally Advanced or Metastatic NSCLC

76 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06357598 2024-04-10

PILOT

Phase 4 Unknown

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

BreastGastrointestinalThoracic

5,000 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT06349252 2024-04-05

Survival Validation and Gene Mutations of N Descriptors in the Ninth Edition of the TNM Classification for Lung Cancer

1,263 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05254119 2024-04-04

REGISTURK-LUNG

6,000 enrolled

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT06344962 2024-04-03

Clinical Effects of Absorbable and Non-absorbable Suture in Bronchial Sleeve Resection

Phase NA Unknown

40 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341387 2024-04-02

Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer

200 enrolled

Carcinoma, Non-Small-Cell Lung, Disease, Lung Neoplasms

NCT06341530 2024-04-02

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

33 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06341660 2024-04-02

To Evaluate the Safety and Tolerability of Carbognilumab Combined With Chemotherapy as the First-line Treatment for Patients With KEAP1 Mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer (NSCLC)

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05311618 2024-04-01

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

71 enrolled

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Melanoma, Mesothelioma, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06231680 2024-03-29

Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)

132 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms

NCT06331650 2024-03-26

A Single-arm Pilot Study of First-line Treatment With Carbognilumab Combined With Chemotherapy in Patients With STK11-mutated Advanced or Postoperative Recurrent Non-small Cell Lung Cancer

30 enrolled

Phase EARLY_PHASE1 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02619448 2024-03-25

Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

12 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06326086 2024-03-22

Differences in Rate of Decline in CT-defined Skeletal Muscle Mass and Physical Performance in Patients With Advanced Non-small Cell Lung Cancer Receiving Chemotherapy and Targeted Therapy/Immunotherapy, Before and After Treatment.

240 enrolled

Carcinoma, Non-Small-Cell Lung, Sarcopenia

NCT03322072 2024-03-20

GPS

Phase NA Unknown

28 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04903873 2024-03-15

A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors

110 enrolled

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Prostatic Neoplasms

NCT06285058 2024-03-13

Deep Learning Model Predicts Pathological Complete Response of Lung Cancer Following Neoadjuvant Immunochemotherapy

1,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05872867 2024-03-12

MK-3475-E90

GastrointestinalHead & NeckThoracic

54 enrolled

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Lung Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT06277674 2024-03-08

Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04544748 2024-03-06

A Phase 1 Study of GNR-051 in Subjects With Advanced Malignancies

DermatologicGenitourinaryThoracic

48 enrolled

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Kidney Neoplasms, Lung Neoplasms, Melanoma, Neoplasms, Neoplasms by Histologic Type, Urologic Neoplasms

NCT06293833 2024-03-05

ZORALCS

Phase NA Unknown

700 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Smoking Cessation, Small Cell Lung Carcinoma

NCT03865511 2024-02-28

MELROSE

150 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06281860 2024-02-28

PITHAC

BreastGastrointestinalGynecologicOther solid neoplasmThoracic

39 enrolled

Mesothelioma, Malignant, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms

NCT06267144 2024-02-20

Detection of Minimal Residual Disease in Resectable Stage II-IIIB Non-small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03924466 2024-02-16

VUBAR